Literature DB >> 17446037

[L-thyroxine pseudomalabsorption: a factitious disease].

Laurent Molines1, Isabelle Fromont, Nathalie Morlet-Barla, Juan-Patricio Nogueira, René Valéro, Bernard Vialettes.   

Abstract

INTRODUCTION: Thyroxine supplementation of patients with hypothyroidism is usually simple. A few patients, however, continue to present elevated TSH levels despite large doses of L-thyroxine. CASE: We report the case of a 71-year-old women who had had a thyroidectomy 10 years earlier and had since been hospitalized repeatedly for profound hypothyroidism. Despite her consistent claims of good adherence to her treatment regimen, we considered the diagnosis of L-thyroxine pseudomalabsorption and confirmed it by thyroid hormone absorption tests. DISCUSSION: L-thyroxine pseudomalabsorption due to concealed poor treatment adherence should be considered after ruling out drug or dietary interference and true organic malabsorption. Diagnosis of this factitious disease can be confirmed by L-thyroxine absorption tests.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446037     DOI: 10.1016/j.lpm.2006.09.024

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  Pseudomalabsorption of Levothyroxine: A Challenge for the Endocrinologist in the Treatment of Hypothyroidism.

Authors:  Nancy Van Wilder; Bert Bravenboer; Sarah Herremans; Nathalie Vanderbruggen; Brigitte Velkeniers
Journal:  Eur Thyroid J       Date:  2016-11-24

2.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

3.  Levothyroxine pseudo-malabsorption: testing and treatment in the outpatient setting.

Authors:  Grzegorz M Rdzak; Laura M Whitman; Silvio E Inzucchi
Journal:  Ther Adv Endocrinol Metab       Date:  2018-04-28       Impact factor: 3.565

4.  Primary hypothyroid induced by drug interaction.

Authors:  Martin Diarra; Youssef Khabbal; Saïd Boujraf; Farida Ajdi
Journal:  Indian J Endocrinol Metab       Date:  2014-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.